Evaluation of a novel infrared range vibration-based descriptor (EVA) for QSAR studies. 1. General application

A novel molecular descriptor (EVA) based upon calculated infrared range vibrational frequencies is evaluated for use in QSAR studies. The descriptor is invariant to both translation and rotation of the structures concerned. The method was applied to 11 QSAR datasets exhibiting both a range of biological endpoints and various degrees of structural diversity. This study demonstrates that robust QSAR models can be obtained using the EVA descriptor and examines the effect of EVA parameter changes on these models; recommendations are made as to the appropriate choice of parameters. The performance of EVA was found to be comparable in statistical terms to that of CoMFA, despite the fact that EVA does not require the generation of a structural alignment. Models derived using semiempirical (MOPAC AM1 and PM3) and AMBER mechanics calculated normal mode frequencies are compared, with the overall conclusion that the semiempirical methods perform equally well and both outperform the AMBER-based models.

[1]  D. Hoekman.  Exploring QSAR Fundamentals and Applications in Chemistry and Biology, Volume 1. Hydrophobic, Electronic and Steric Constants, Volume 2 J. Am. Chem. Soc. 1995, 117, 9782 , 1996 .

[2]  U. Singh,et al.  A NEW FORCE FIELD FOR MOLECULAR MECHANICAL SIMULATION OF NUCLEIC ACIDS AND PROTEINS , 1984 .

[3]  Ki Hwan Kim,et al.  Use of the hydrogen bond potential function in a comparative molecular field analysis (CoMFA) on a set of benzodiazepines , 1993, J. Comput. Aided Mol. Des..

[4]  M. Karelson,et al.  Quantum-Chemical Descriptors in QSAR/QSPR Studies. , 1996, Chemical reviews.

[5]  Sorel Muresan,et al.  Van der Waals Intersection Envelope Volumes as a Possible Basis for Steric Interaction in CoMFA , 1996 .

[6]  B D Silverman,et al.  Comparative molecular moment analysis (CoMMA): 3D-QSAR without molecular superposition. , 1996, Journal of medicinal chemistry.

[7]  G. Herzberg,et al.  Molecular Spectra and Molecular Structure , 1992 .

[8]  A. Good,et al.  Structure-activity relationships from molecular similarity matrices. , 1993, Journal of medicinal chemistry.

[9]  Peter Willett,et al.  Similarity Searching in Files of Three-Dimensional Chemical Structures: Evaluation of the EVA Descriptor and Combination of Rankings Using Data Fusion , 1997, J. Chem. Inf. Comput. Sci..

[10]  Richard D. Cramer,et al.  BC(DEF) parameters. 1. The intrinsic dimensionality of intermolecular interactions in the liquid state , 1980 .

[11]  Romano T. Kroemer,et al.  A new procedure for improving the predictiveness of CoMFA models and its application to a set of dihydrofolate reductase inhibitors , 1995, J. Comput. Aided Mol. Des..

[12]  F I Carroll,et al.  Synthesis, ligand binding, QSAR, and CoMFA study of 3 beta-(p-substituted phenyl)tropane-2 beta-carboxylic acid methyl esters. , 1991, Journal of medicinal chemistry.

[13]  G. Klebe,et al.  Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. , 1994, Journal of medicinal chemistry.

[14]  Philip Jonathan,et al.  Discriminant analysis with singular covariance matrices. A method incorporating cross‐validation and efficient randomized permutation tests , 1996 .

[15]  C. Waller,et al.  Comparative molecular field analysis of polyhalogenated dibenzo-p-dioxins, dibenzofurans, and biphenyls. , 1992, Journal of medicinal chemistry.

[16]  Yvonne C. Martin,et al.  DIRECT PREDICTION OF LINEAR FREE ENERGY SUBSTITUENT EFFECTS FROM 3D STRUCTURES USING COMPARATIVE MOLECULAR FIELD ANALYSIS. I, ELECTRONIC EFFECTS OF SU BSTITUTED BENZOIC ACIDS , 1991 .

[17]  C. Hansch,et al.  p-σ-π Analysis. A Method for the Correlation of Biological Activity and Chemical Structure , 1964 .

[18]  R. Cramer,et al.  Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.

[19]  A. N. Jain,et al.  Compass: predicting biological activities from molecular surface properties. Performance comparisons on a steroid benchmark. , 1994, Journal of medicinal chemistry.

[20]  A. Doweyko,et al.  The hypothetical active site lattice. An approach to modelling active sites from data on inhibitor molecules. , 1988, Journal of medicinal chemistry.

[21]  Ettore Novellino,et al.  Comparative Molecular Field Analysis on a Set of Muscarinic Agonists , 1991 .

[22]  A Tropsha,et al.  Cross-validated R2-guided region selection for comparative molecular field analysis: a simple method to achieve consistent results. , 1995, Journal of medicinal chemistry.

[23]  Glen Eugene Kellogg,et al.  HINT: A new method of empirical hydrophobic field calculation for CoMFA , 1991, J. Comput. Aided Mol. Des..

[24]  F I Carroll,et al.  Synthesis and ligand binding of cocaine isomers at the cocaine receptor. , 1991, Journal of medicinal chemistry.

[25]  J. McFarland,et al.  Comparative molecular field analysis of anticoccidial triazines. , 1992, Journal of medicinal chemistry.

[26]  D. E. Clark,et al.  PRO_LIGAND: an approach to de novo molecular design. 2. Design of novel molecules from molecular field analysis (MFA) models and pharmacophores. , 1994, Journal of medicinal chemistry.

[27]  Allan M. Ferguson,et al.  EVA: A new theoretically based molecular descriptor for use in QSAR/QSPR analysis , 1997, J. Comput. Aided Mol. Des..

[28]  K F Koehler,et al.  Predictive binding of beta-carboline inverse agonists and antagonists via the CoMFA/GOLPE approach. , 1992, Journal of medicinal chemistry.

[29]  Anton J. Hopfinger,et al.  A 3D-QSAR Study of Anticoccidial Triazines Using Molecular Shape Analysis , 1995, J. Chem. Inf. Comput. Sci..

[30]  J. Topliss,et al.  Chance factors in studies of quantitative structure-activity relationships. , 1979, Journal of medicinal chemistry.

[31]  Anton J. Hopfinger,et al.  A 3D-QSAR Study of Anticoccidial Triazines Using Molecular Shape Analysis [J. Chem. Inf. Comput. Sci 35, 771-778 (1995)] , 1996, J. Chem. Inf. Comput. Sci..

[32]  G M Crippen,et al.  Modeling the benzodiazepine receptor binding site by the general three-dimensional structure-directed quantitative structure-activity relationship method REMOTEDISC. , 1990, Molecular pharmacology.

[33]  J. Gasteiger,et al.  Autocorrelation of Molecular Surface Properties for Modeling Corticosteroid Binding Globulin and Cytosolic Ah Receptor Activity by Neural Networks , 1995 .

[34]  D. Rogers,et al.  Receptor surface models. 2. Application to quantitative structure-activity relationships studies. , 1995, Journal of medicinal chemistry.

[35]  Paola Gramatica,et al.  Modeling and prediction by using WHIM descriptors in QSAR studies: Toxicity of heterogeneous chemicals on Daphnia magna , 1996 .